LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 58 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $136,000 | +23.6% | 499,932 | +59.4% | 0.00% | – |
Q2 2022 | $110,000 | -49.5% | 313,703 | -2.5% | 0.00% | – |
Q1 2022 | $218,000 | -87.0% | 321,603 | -55.7% | 0.00% | – |
Q4 2021 | $1,678,000 | -49.9% | 726,364 | -0.6% | 0.00% | – |
Q3 2021 | $3,346,000 | +5.3% | 730,572 | +2.1% | 0.00% | – |
Q2 2021 | $3,178,000 | -45.4% | 715,782 | -10.5% | 0.00% | – |
Q1 2021 | $5,822,000 | -3.1% | 799,725 | +1.6% | 0.00% | – |
Q4 2020 | $6,009,000 | +98.3% | 787,478 | +135.9% | 0.00% | – |
Q3 2020 | $3,031,000 | +6.6% | 333,842 | -0.7% | 0.00% | – |
Q2 2020 | $2,844,000 | +81.6% | 336,167 | +6.1% | 0.00% | – |
Q1 2020 | $1,566,000 | -31.3% | 316,947 | +0.1% | 0.00% | – |
Q4 2019 | $2,279,000 | -33.8% | 316,531 | -0.6% | 0.00% | – |
Q3 2019 | $3,442,000 | -4.7% | 318,336 | +14.6% | 0.00% | – |
Q2 2019 | $3,612,000 | +35.3% | 277,859 | +2.8% | 0.00% | – |
Q1 2019 | $2,670,000 | +18.9% | 270,271 | +25.2% | 0.00% | – |
Q4 2018 | $2,245,000 | – | 215,901 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 6,466,783 | $69,906,000 | 1.33% |
Board of Trustees of The Leland Stanford Junior University | 949,443 | $10,264,000 | 1.11% |
Lion Point Capital, LP | 500,000 | $5,405,000 | 0.60% |
Sio Capital Management, LLC | 122,536 | $1,325,000 | 0.43% |
Redmile Group, LLC | 749,026 | $8,097,000 | 0.27% |
SAMLYN CAPITAL, LLC | 639,977 | $6,918,000 | 0.17% |
Stanley-Laman Group, Ltd. | 19,530 | $211,000 | 0.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,378,475 | $14,901,000 | 0.04% |
FRANKLIN RESOURCES INC | 700,000 | $7,567,000 | 0.00% |
Jefferies Group LLC | 10,618 | $115,000 | 0.00% |